$-0.01 EPS Expected for Pharma Bio Serv Inc (PBSV)

August 23, 2017 – By Vivian Park

 $ 0.01 EPS Expected for Pharma Bio Serv Inc (PBSV)

Wall Street await Pharma Bio Serv Inc (OTCMKTS:PBSV) to release earnings on September, 13. Analysts forecast earnings per share of $-0.01, exactly $0.00 or 0.00 % from 2014’s $-0.01 EPS. After posting $-0.01 EPS for the previous quarter, Pharma Bio Serv Inc’s analysts now forecast 0.00 % EPS growth. It is down 0.00% since August 23, 2016 and is . It has underperformed by 16.70% the S&P500.

Pharma-Bio Serv, Inc. is a compliance and technology transfer services consulting company. The company has market cap of $15.59 million. The Firm operates through four divisions: Puerto Rico technical compliance consulting, United States technical compliance consulting, Europe technical compliance consulting, and Puerto Rico microbiological and chemical laboratory testing division . It currently has negative earnings. The Firm provides a range of compliance-related consulting services.

More news for Pharma Bio Serv Inc (OTCMKTS:PBSV) were recently published by: Marketwired.com, which released: “Pharma-Bio Serv Signs Strategic Collaboration Agreement With Quality Technical …” on October 09, 2014. Seekingalpha.com‘s article titled: “What Is Pharma-Bio Serv’s Goal With An M&A Advisor?” and published on November 20, 2015 is yet another important article.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts’ ratings for your stocks with our free daily email newsletter:

Recent Posts